|
|
|
Volumn 5, Issue 2, 1999, Pages 475-476
|
|
Correspondence re: V. I. Avramis et al., Pharmacokinetic and pharmacodynamic studies of fludarabine and cytosine arabinoside administered as loading boluses followed by continuous infusions after a phase I/II study in pediatric patients with relapsed leukemias. Clin. Cancer Res., 4: 45-52, 1998 - Fludarabine: Phosphate or no phosphate, that is the confusion
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CYTARABINE;
FLUDARABINE;
ANTINEOPLASTIC AGENT;
DRUG DERIVATIVE;
FLUDARABINE PHOSPHATE;
VIDARABINE;
VIDARABINE PHOSPHATE;
CANCER COMBINATION CHEMOTHERAPY;
CANCER RESEARCH;
CHILDHOOD LEUKEMIA;
CLINICAL TRIAL;
CONTINUOUS INFUSION;
DRUG RESEARCH;
HUMAN;
LETTER;
PEDIATRICS;
PHARMACODYNAMICS;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
CHILD;
LEUKEMIA;
NOMENCLATURE;
NOTE;
PRESCHOOL CHILD;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CHILD;
CHILD, PRESCHOOL;
CLINICAL TRIALS, PHASE I;
CLINICAL TRIALS, PHASE II;
CYTARABINE;
HUMANS;
LEUKEMIA;
TERMINOLOGY;
VIDARABINE;
VIDARABINE PHOSPHATE;
|
|
EID: 0032588966
PISSN: 10780432
EISSN: None
Source Type: Journal
DOI: None Document Type: Letter |
|
Times cited : (2)
|
|
References (0)
|
